Why the study?
Do in-series techniques offer advantages over parallel-assist techniques in patients with left-sided congestive heart failure?
Do in-series techniques offer advantages over parallel-assist techniques in patients with left-sided congestive heart failure?
Answers are grounded in this paper and cite their sources.
In-series mechanical assist techniques offer advantages in reliability, simplicity, and safety during deactivation compared to parallel-assist techniques for patients with left-sided heart failure.
A spectrum of techniques for restoring cardiac function is emerging. Among patients with global congestive heart failure (CHF), cardiac transplantation may help a small minority for whom allografts are available; the total artificial heart may eventually benefit a larger number. For patients with left-sided CHF, parallel-assist techniques maximally augment cardiac output. In-series techniques can help others without major arrhythmias and some residual cardiac output. As compared with parallel assist, in-series methods offer lesser hemodynamic augmentation but greater intrinsic reliability and the possibility of deactivation of support for hours or days without increased risk. Additional advantages include simplicity of management and documented long-term clinical efficacy.
No takes yet. Share an insight, caveat, or question.
Ádrian Kantrowitz (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: